S1P在哮喘中的研究现状及应用前景

doi:10.3969/j.issn.1006-5725.2024.07.010

Abstract

Abstract:

Asthma is a chronic inflammatory airway disease， and airway inflammation， airway hyper?responsiveness and airway remodeling are the major pathological alterations in asthma. Numerous studies have demonstrated sphingosine metabolism disorders exist in asthma patients， and sphingosine?1?phosphate （S1P） is the end product of sphingolipid metabolism， which has become the focus of research as an important mediator of immune and inflammatory diseases， and is closely related to the development of asthma. In this paper， we summarize the role of S1P in the pathological changes of asthma from the relationship between S1P and asthma as well as its application in the clinical diagnosis， treatment and efficacy assessment of asthma， with a view to exploring more directions in the diagnosis and treatment of asthma。

Key words: sphingosine?1?phosphate, asthma, mechanism, clinical application, biomarker

CLC Number:

R256.12

Chen YUAN,Xia ZHAO,Jiabao WU,Hua. YAN. Current research status and application prospects of S1P in asthma[J]. The Journal of Practical Medicine, 2024, 40(7): 936-940.

References 42

1	洪建国. 儿童支气管哮喘规范化诊治建议（2020年版）［J］. 中华儿科杂志， 2020，58（9）：708-717.
2	HUANG K， YANG T， XU J， et al. Prevalence， risk factors， and management of asthma in China： a nationa l cross-sectional study［J］. Lancet， 2019，394（10196）：407-418. doi:10.1016/s0140-6736(19)31147-x doi: 10.1016/s0140-6736(19)31147-x
3	中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南（2020年版）［J］. 中华结核和呼吸杂志， 2020，43（12）：1023-1048. doi:10.3760/cma.j.cn112147-20200618-00721 doi: 10.3760/cma.j.cn112147-20200618-00721
4	DÍAZ-PERALES A， ESCRIBESE M M， GARRIDO-ARANDIA M， et al. The Role of Sphingolipids in Allergic Disorders［J］. Front Allergy， 2021，2：675557. doi:10.3389/falgy.2021.675557 doi: 10.3389/falgy.2021.675557
5	WANG S， TIAN Z， LU Y， et al. Sphingosine-1-Phosphate Receptor 4 Attenuates Neutrophilic Airway Infl ammation in Experimental Asthma via Repressing Proinflammatory Macroph age Activation［J］. Int J Biol Sci， 2023，19（5）：1597-1615. doi:10.7150/ijbs.80256 doi: 10.7150/ijbs.80256
6	LEE M， LEE S Y， BAE Y. Functional roles of sphingolipids in immunity and their implication in disease［J］. Exp Mol Med，2023，55（6）：1110-1130. doi:10.1038/s12276-023-01018-9 doi: 10.1038/s12276-023-01018-9
7	HLA T， DANNENBERG A J. Sphingolipid signaling in metabolic disorders［J］. Cell Metab， 2012，16（4）：420-434. doi:10.1016/j.cmet.2012.06.017 doi: 10.1016/j.cmet.2012.06.017
8	BRESLOW D K， COLLINS S R， BODENMILLER B， et al. Orm family proteins mediate sphingolipid homeostasis［J］. Nature， 2010，463（7284）：1048-1053. doi:10.1038/nature08787 doi: 10.1038/nature08787
9	JAMES B， MILSTIEN S， SPIEGEL S. ORMDL3 and allergic asthma： From physiology to pathology［J］. J Allergy Clin Immunol， 2019，144（3）：634-640. doi:10.1016/j.jaci.2019.07.023 doi: 10.1016/j.jaci.2019.07.023
10	BAEYENS A， BRACERO S， CHALUVADI V S， et al. Monocyte-derived S1P in the lymph node regulates immune responses［J］. Nature， 2021，592（7853）：290-295. doi:10.1038/s41586-021-03227-6 doi: 10.1038/s41586-021-03227-6
11	BAEYENS A A L， SCHWAB S R. Finding a Way Out： S1P Signaling and Immune Cell Migration［J］. Annu Rev Immunol， 2020，38：759-784. doi:10.1146/annurev-immunol-081519-083952 doi: 10.1146/annurev-immunol-081519-083952
12	TERASHITA T， KOBAYASHI K， NAGANO T， et al. Administration of JTE013 abrogates experimental asthma by regulating proinflammatory cytokine production from bronchial epithelial cells［J］. Respir Res， 2016，17（1）：146. doi:10.1186/s12931-016-0465-x doi: 10.1186/s12931-016-0465-x
13	KAWA Y， NAGANO T， YOSHIZAKI A， et al. Role of S1P/S1PR3 axis in release of CCL20 from human bronchial epithelial cells［J］. PLoS One， 2018，13（9）：e203211. doi:10.1371/journal.pone.0203211 doi: 10.1371/journal.pone.0203211
14	OSKERITZIAN C A， PRICE M M， HAIT N C， et al. Essential roles of sphingosine-1-phosphate receptor 2 in human mast cell activation， anaphylaxis， and pulmonary edema［J］. J Exp Med， 2010，207（3）：465-474. doi:10.1084/jem.20091513 doi: 10.1084/jem.20091513
15	JEON W， CHUNG K W， LEE J， et al. Suppressive Effect of CYM50358 S1P₄ Antagonist on Mast Cell Degranulation and Allergic Asthma in Mice［J］. Biomol Ther， 2021，29（5）：492-497. doi:10.4062/biomolther.2020.206 doi: 10.4062/biomolther.2020.206
16	段留路，董航明，蔡绍曦. 哮喘急性发作气道炎症表型变化研究进展［J］. 实用医学杂志， 2018，34（12）：1923-1925. doi:10.3969/j.issn.1006-5725.2018.12.001 doi: 10.3969/j.issn.1006-5725.2018.12.001
17	JAMES B N， WEIGEL C， GREEN C D， et al. Neutrophilia in severe asthma is reduced in Ormdl3 overexpressing mice［J］. FASEB J， 2023，37（3）：e22799. doi:10.1096/fj.202201821r doi: 10.1096/fj.202201821r
18	WEICHAND B， POPP R， DZIUMBLA S， et al. S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and m etastasis via NLRP3/IL-1β［J］. J Exp Med， 2017，214（9）：2695-2713. doi:10.1084/jem.20160392 doi: 10.1084/jem.20160392
19	张文路，徐春燕. SphK1/S1P在肿瘤恶性生物学行为中的研究进展［J］. 实用医学杂志， 2023，39（19）：2551-2555. doi:10.3969/j.issn.1006-5725.2023.19.024 doi: 10.3969/j.issn.1006-5725.2023.19.024
20	ROVIEZZO F， D'AGOSTINO B， BRANCALEONE V， et al. Systemic administration of sphingosine-1-phosphate increases bronchial hyperresponsiveness in the mouse［J］. Am J Resp Cell Mol， 2010，42（5）：572-577. doi:10.1165/rcmb.2009-0108oc doi: 10.1165/rcmb.2009-0108oc
21	PAN Y， LIU L， ZHANG Q， et al. Activation of AMPK suppresses S1P-induced airway smooth muscle cells proliferation and its potential mechanisms［J］. Mol Immunol， 2020，128：106-115. doi:10.1016/j.molimm.2020.09.020 doi: 10.1016/j.molimm.2020.09.020
22	MAGUIRE T J A， YUNG S， ORTIZ-ZAPATER E， et al. Sphingosine-1-phosphate induces airway smooth muscle hyperresponsiveness and proliferation［J］. J Allergy Clin Immunol， 2023：S91-S6749. doi:10.1016/j.jaci.2023.05.028 doi: 10.1016/j.jaci.2023.05.028
23	PATIL M J， MEEKER S， BAUTISTA D， et al. Sphingosine-1-phosphate activates mouse vagal airway afferent C-fibres via S1PR3 receptors［J］. J Physiol， 2019，597（7）：2007-2019. doi:10.1113/jp277521 doi: 10.1113/jp277521
24	HAN L， LIMJUNYAWONG N， RU F， et al. Mrgprs on vagal sensory neurons contribute to bronchoconstriction and airway hyper-responsiveness［J］. Nat Neurosci， 2018，21（3）：324-328. doi:10.1038/s41593-018-0074-8 doi: 10.1038/s41593-018-0074-8
25	KONO Y， NISHIUMA T， OKADA T， et al. Sphingosine kinase 1 regulates mucin production via ERK phosphorylation［J］. Pulm Pharmacol Ther， 2009，23（1）：36-42. doi:10.1016/j.pupt.2009.10.005 doi: 10.1016/j.pupt.2009.10.005
26	LIU H， LI L， CHEN Z， et al. S1PR2 Inhibition Attenuates Allergic Asthma Possibly by Regulating Autophagy［J］. Front Pharmacol， 2021，11：598007. doi:10.3389/fphar.2020.598007 doi: 10.3389/fphar.2020.598007
27	FUERST E， FOSTER H R， WARD J P T， et al. Sphingosine-1-phosphate induces pro-remodelling response in airway smooth muscle cells［J］. Allergy， 2016，69（11）：1531-1539.
28	RIEMMA M A， CERQUA I， ROMANO B， et al. Sphingosine-1-phosphate/TGF-β axis drives epithelial mesenchymal transition in asthma-like disease［J］. Brit J Pharmacol， 2022，179（8）：1753-1768. doi:10.1111/bph.15754 doi: 10.1111/bph.15754
29	宋云熙，王东霞，王英，等. 血清S1P、SFRP1、TIM4、SFRP5与成人支气管哮喘急性发作期患者肺功能、气道炎症和治疗后再次急性复发的关系［J］. 现代生物医学进展， 2022，22（8）：1519-1523.
30	王娜. 小儿支气管哮喘血清中S1P、TNC表达变化及其与疾病严重程度的关系［J］. 医学理论与实践， 2021，34（19）：3443-3444.
31	厉玉鹏，吕倩倩. 血清S1P水平在哮喘患儿治疗药物调整中的临床研究［J］. 临床肺科杂志， 2020，25（12）：1849-1854. doi:10.3969/j.issn.1009-6663.2020.12.016 doi: 10.3969/j.issn.1009-6663.2020.12.016
32	MCGINLEY M P， COHEN J A. Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions［J］. Lancet （London， England）， 2021，398（10306）：1184-1194. doi:10.1016/s0140-6736(21)00244-0 doi: 10.1016/s0140-6736(21)00244-0
33	MAKLED M N， EL-SHEAKH A R. Fingolimod attenuates ovalbumin-induced airway inflammation via inhibiting MAPK/ERK signaling in mice［J］. J Biochem Mol Toxic， 2023，37（3）：e23266. doi:10.1002/jbt.23266 doi: 10.1002/jbt.23266
34	KIM S H， UUGANBAYAR U， TRINH H K T， et al. Evaluation of Neutrophil Activation Status According to the Phenotypes of Adult Asthma［J］. Allergy Asthma Immunol Res， 2019，11（3）：381-393. doi:10.4168/aair.2019.11.3.381 doi: 10.4168/aair.2019.11.3.381
35	BU Y， WU H， DENG R， et al. Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases［J］. Front Pharmacol， 2021，12：733387. doi:10.3389/fphar.2021.733387 doi: 10.3389/fphar.2021.733387
36	GENDRON D R， LECOURS P B， LEMAY A， et al. A Phosphorylatable Sphingosine Analog Induces Airway Smooth Muscle Cytostasis and Reverses Airway Hyperresponsiveness in Experimental Asthma［J］. Front Pharmacol， 2017，8：78. doi:10.3389/fphar.2017.00078 doi: 10.3389/fphar.2017.00078
37	温家让. 舒喘通络饮治疗支气管哮喘急性发作期（风痰阻肺兼血瘀证）的临床观察及其对血清S1P的影响［D］. 哈尔滨：黑龙江中医药大学， 2023.
38	王海浪，黄绘群，徐娇. 小儿哮喘行肺力咳合剂联合氨溴索治疗对肺功能、致炎因子、ADAM33、S1P的影响［J］. 实用中西医结合临床， 2022，22（8）：40-43.
39	李红华. 冬病夏治穴位贴敷治疗支气管哮喘临床疗效及对血清S1P、LXA4表达水平影39响［J］. 辽宁中医药大学学报， 2022，24（2）：153-156.
40	傅榕冰. 化痰活血方通过抑制ILC2s干预哮喘的作用及机制研究［D］. 昆明：云南中医药大学， 2020.
41	肖湘，魏颍，董艳，等. 黄龙舒喘汤调控S1P/S1PR通路干预大鼠气道高反应的效应机制研究［J］. 时珍国医国药， 2023，34（3）：525-529. doi:10.3969/j.issn.1008-0805.2023.03.04 doi: 10.3969/j.issn.1008-0805.2023.03.04
42	杨睿雪. 基于“益气固表”理论探讨SPHK1在哮喘气道上皮屏障功能损伤中的作用及固本防哮饮的干预作用［D］. 南京：南京中医药大学， 2018.

[1]	Qiaoyan GUAN,Songyu BAO,Yuanyuan CUI,Siming. LI. Research progress of the mechanisms of fatigue in Long COVID patients [J]. The Journal of Practical Medicine, 2024, 40(9): 1186-1190.
[2]	Yonghui LIU,Qingjing TAN,Qing CHEN,Liping WEI,Junwei YANG,Kan YANG,Yuguang. GAO. The mechanism of target regulating of miR⁃421 to Menin/Caspase⁃3 pathway for depression [J]. The Journal of Practical Medicine, 2024, 40(4): 453-459.
[3]	Yimei HUANG,Lulu ZHAO,Baotong. HUA. Application effect of insertable cardiac monitorin atrial fibrillation monitoring [J]. The Journal of Practical Medicine, 2024, 40(21): 3095-3100.
[4]	Shengnan JIANG,Wenbing ZHI,Jing CHEN,Tingting SUN,Zongren XU,Shuai LIU,Hong ZHANG,Ye LI,Yang LIU. Sophora davidii Hance leaves total alkaloids Attenuate Lipopolysaccharide-induced inflammatory response in RAW264.7 cell by Inhibiting the MAPK/NF-κB signaling pathway [J]. The Journal of Practical Medicine, 2024, 40(20): 2835-2840.
[5]	Tianyue YU,Qian GUO,Hao HU,Yujing SU,Jianhua CHEN. Advances in oxidative stress⁃related pathways with diagnostic and predictive value in schizophrenia [J]. The Journal of Practical Medicine, 2024, 40(20): 2935-2940.
[6]	Ling TAN,Xue MA,Jingjing WANG,Fengfeng LEI. Research progress of matrix metalloproteinase⁃28 in pulmonary disease [J]. The Journal of Practical Medicine, 2024, 40(20): 2949-2953.
[7]	Yangyang CHEN,Hongqi MA,Jing YANG,Zongyue WU,Ping. ZHU. Impact of Atractylodin on lung tissue damage in young asthma rats by regulating the CXCL12/CXCR4 signaling pathway [J]. The Journal of Practical Medicine, 2024, 40(19): 2672-2677.
[8]	Shuting YANG,Shuoming LUO,Zhiguang. ZHOU. A new vision of diabetes classification： A shift from clinical manifestation to etiological molecular mechanism [J]. The Journal of Practical Medicine, 2024, 40(16): 2199-2205.
[9]	Kaming YANG,Zhenlin LI,Wanwen LAO,Aixia ZHAI,Changlong. BI. Serological biomarkers for diagnosis of diabetes foot： A review of literature [J]. The Journal of Practical Medicine, 2024, 40(16): 2224-2228.
[10]	Ganggang LU,Shenglong LI,Yongqiang ZHAO,Yunpeng JIA,Yonglin LIANG,Yuanbo. ZHAO. Research progress on the correlation between oxidative stress and ferroptosis in diabetic impotence [J]. The Journal of Practical Medicine, 2024, 40(16): 2229-2235.
[11]	Jiao XU,Min ZHANG,Guogang. XIE. Research progress of mast cell⁃derived exosomes in bronchial asthma [J]. The Journal of Practical Medicine, 2024, 40(15): 2194-2198.
[12]	Jie YANG,Chunhong LI,Jingfei HUANG,Zhiwei CHEN,Lin. LIU. The expression and clinical significance of hsa_circ_0003922 in endometrioid carcinoma [J]. The Journal of Practical Medicine, 2024, 40(14): 1975-1980.
[13]	Chunling PAN,Xueli YI,Li SU,Shengshan YUAN,Guijiang WEI. Research progress of circrna and atherosclerotic ischemic stroke [J]. The Journal of Practical Medicine, 2024, 40(12): 1755-1761.
[14]	Jie SHEN,Guihua. XU. Research progress in the relationship between Alzheimer′s disease and blood⁃brain barrier [J]. The Journal of Practical Medicine, 2024, 40(11): 1602-1606.
[15]	ZOU Hanyu, CHEN Xiang, ZHAO Lijuan, ZHANG Guohui, ZHANG Hong.. Mechanism of traction in the treatment of cervical radiculopathy：a review of literature [J]. The Journal of Practical Medicine, 2023, 39(7): 793-797.

Current research status and application prospects of S1P in asthma

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 42

Related Articles 15

Recommended Articles

Metrics

Comments